557 related articles for article (PubMed ID: 11274076)
1. Blockade of CD40-CD154 costimulatory pathway promotes survival of allogeneic corneal transplants.
Qian Y; Boisgerault F; Benichou G; Dana MR
Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):987-94. PubMed ID: 11274076
[TBL] [Abstract][Full Text] [Related]
2. Effect of locally administered anti-CD154 (CD40 ligand) monoclonal antibody on survival of allogeneic corneal transplants.
Qian Y; Dana MR
Cornea; 2002 Aug; 21(6):592-7. PubMed ID: 12131037
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of immunotherapeutic intervention by anti-CD154 (CD40L) antibody in high-risk corneal transplantation.
Qian Y; Hamrah P; Boisgerault F; Yamagami S; Vora S; Benichou G; Dana MR
J Interferon Cytokine Res; 2002 Dec; 22(12):1217-25. PubMed ID: 12581495
[TBL] [Abstract][Full Text] [Related]
4. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
Li JM; Gorechlad J; Larsen CP; Waller EK
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
[TBL] [Abstract][Full Text] [Related]
5. Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.
Pan Y; Luo B; Sozen H; Kalscheuer H; Blazar BR; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2003 Jul; 76(1):216-24. PubMed ID: 12865813
[TBL] [Abstract][Full Text] [Related]
6. MHC-matched corneal allograft rejection in an IFN-gamma/IL-17-independent manner in C57BL/6 mice.
Yamada J; Hamuro J; Fukushima A; Ohteki T; Terai K; Iwakura Y; Yagita H; Kinoshita S
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2139-46. PubMed ID: 19136699
[TBL] [Abstract][Full Text] [Related]
7. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice.
Yamada J; Kurimoto I; Streilein JW
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2614-21. PubMed ID: 10509657
[TBL] [Abstract][Full Text] [Related]
8. Preservation of donor cornea prevents corneal allograft rejection by inhibiting induction of alloimmunity.
Kamiya K; Hori J; Kagaya F; Usui T; Amano S; Oshika T; Mizouchi T; Tsuru T; Yamagami S
Exp Eye Res; 2000 Jun; 70(6):737-43. PubMed ID: 10843778
[TBL] [Abstract][Full Text] [Related]
9. Murine orthotopic corneal transplantation in high-risk eyes. Rejection is dictated primarily by weak rather than strong alloantigens.
Sano Y; Ksander BR; Streilein JW
Invest Ophthalmol Vis Sci; 1997 May; 38(6):1130-8. PubMed ID: 9152232
[TBL] [Abstract][Full Text] [Related]
10. Neutralizing interleukin-4 prevents transplant arteriosclerosis mediated by indirect pathway T cells under CD40-CD154 costimulation blockade.
Spriewald BM; Ensminger SM; Bushell A; Wood KJ
Transplantation; 2008 Dec; 86(11):1615-21. PubMed ID: 19077898
[TBL] [Abstract][Full Text] [Related]
11. T-cell mediated responses in a murine model of orthotopic corneal transplantation.
Joo CK; Pepose JS; Stuart PM
Invest Ophthalmol Vis Sci; 1995 Jul; 36(8):1530-40. PubMed ID: 7601633
[TBL] [Abstract][Full Text] [Related]
12. Blockade of the OX40 ligand prolongs corneal allograft survival.
Hattori T; Usui Y; Okunuki Y; Sonoda Y; Usui M; Takada E; Mizuguchi J; Yagita H; Okumura K; Akiba H; Takeuchi M
Eur J Immunol; 2007 Dec; 37(12):3597-604. PubMed ID: 18022861
[TBL] [Abstract][Full Text] [Related]
13. Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction.
Sano Y; Ksander BR; Streilein JW
Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2176-85. PubMed ID: 7558710
[TBL] [Abstract][Full Text] [Related]
14. The effect of simultaneous CD154 and LFA-1 blockade on the survival of allogeneic islet grafts in nonobese diabetic mice.
Berney T; Pileggi A; Molano RD; Poggioli R; Zahr E; Ricordi C; Inverardi L
Transplantation; 2003 Dec; 76(12):1669-74. PubMed ID: 14688513
[TBL] [Abstract][Full Text] [Related]
15. T cell subsets in the immune rejection of murine heterotopic corneal allografts.
Matoba AY; Peeler JS; Niederkorn JY
Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1244-54. PubMed ID: 2942516
[TBL] [Abstract][Full Text] [Related]
16. Langerhans cells, orthotopic corneal allografts, and direct and indirect pathways of T-cell allorecognition.
Sano Y; Ksander BR; Streilein JW
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1422-31. PubMed ID: 10798658
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of costimulatory pathway modulation on corneal allograft survival.
Watson MP; George AJ; Larkin DF
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3417-22. PubMed ID: 16877411
[TBL] [Abstract][Full Text] [Related]
18. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice.
Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T
Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869
[TBL] [Abstract][Full Text] [Related]
19. Characterization of cell-mediated immune responses elicited by orthotopic corneal allografts in mice.
Sonoda Y; Sano Y; Ksander B; Streilein JW
Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):427-34. PubMed ID: 7843911
[TBL] [Abstract][Full Text] [Related]
20. The critical role of lymph nodes in corneal alloimmunization and graft rejection.
Yamagami S; Dana MR
Invest Ophthalmol Vis Sci; 2001 May; 42(6):1293-8. PubMed ID: 11328742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
